Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - ping+wang
Rapid and ultrasensitive SARS-CoV-2 antigen detection for acute COVID-19 screening in community settings
rss.brief>A portable point-of-care device for rapid and sensitive detection of acute SARS-CoV-2 infections. Problem: The COVID-19 pandemic has infected over 40 million people worldwide as of mid-October 2020, causing more than 1 million deaths. Up to 50-80% of transmissions occur from asymptomatic patients. Current tests can have a turnaround time...
A point-of-care fentanyl test capable of detecting ≥1 ng/ml fentanyl
Fentanyl is a synthetic opioid agonist that is almost 50-100 times more potent than morphine, and illicit fentanyl is the fastest growing overdose substance in the United States. Rapid identification of fentanyl in suspected overdose patients is critical for prompt treatment. This invention describes an easy to use point-of-care test to rapidly identify...
Portable assay platform for detection of single molecules
A simple, inexpensive, and portable lateral flow assay platform that uses platinum nanoparticles to amplify signals and achieve single-molecule sensitivity. Technology Overview: Point-of-care (POC) diagnostics are able to provide rapid on-site results in non laboratory settings and play a key role in public health for rural and under-developed...
© 2021. All Rights Reserved. Powered by